Onglyza News
Most Popular Onglyza Story
FDA delays blockbuster diabetes drug decision
A potential new blockbuster diabetes drug will have to sit on the shelf a few months longer as researchers gather up more safety data on the therapy. AstraZeneca and Bristol-Myers Squibb say that the Read more...
Latest Headlines
- September 23, 2011
- August 3, 2009
- June 4, 2009
- April 23, 2009
- September 9, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
